Atlas Trials

Immunotherapy as Second-line in Patient With Small Cell Lung Cancer

Clinical trial NCT03059667 · COMPLETED

Trial details

NCT number
NCT03059667
Sponsor
Intergroupe Francophone de Cancerologie Thoracique
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Small Cell Lung CancerSmall Cell Lung Cancer Limited StageSmall Cell Lung Cancer Extensive Stage
Start date
2017-03-13
Primary completion
2018-09-10
Enrollment
73

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.